IN8bio To Sell 25.8M Shares, 5.6M Pre-Funded Warrants, And 31.4M Series C Warrants At $0.395 Per Unit In Private Placement
Portfolio Pulse from Benzinga Newsdesk
IN8bio is conducting a private placement to sell 25.8 million shares, 5.6 million pre-funded warrants, and 31.4 million Series C warrants at $0.395 per unit.
October 01, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IN8bio is raising capital through a private placement by selling shares and warrants, which may lead to stock dilution.
The private placement involves issuing a significant number of shares and warrants, which could dilute existing shareholders' equity and potentially put downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100